0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Monovalent Antivenom - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-23R6342
Home | Market Reports | Health| Pharmacy
Global Monovalent Antivenom Market Insights Forecast to 2028
BUY CHAPTERS

Monovalent Antivenom - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-23R6342
Report
October 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Monovalent Antivenom - Market Size

The global market for Monovalent Antivenom was estimated to be worth US$ 384 million in 2023 and is forecast to a readjusted size of US$ 477.6 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030

Monovalent Antivenom - Market

Monovalent Antivenom - Market

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Monovalent Antivenom, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Monovalent Antivenom by region & country, by Type, and by Application.
The Monovalent Antivenom market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monovalent Antivenom.
Market Segmentation

Scope of Monovalent Antivenom - Market Report

Report Metric Details
Report Name Monovalent Antivenom - Market
Forecasted market size in 2030 US$ 477.6 million
CAGR 3.1%
Forecasted years 2024 - 2030
Segment by Type:
  • Coral Snakes Antivenom
  • Sea Snakes Antivenom
  • Brown Snake Antivenom
  • Others
Segment by Application
  • Non-profit Institutions
  • Hospitals and Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Vins Bioproducts, Serum Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Monovalent Antivenom manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Monovalent Antivenom in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Monovalent Antivenom in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Monovalent Antivenom - Market size in 2030?

Ans: The Monovalent Antivenom - Market size in 2030 will be US$ 477.6 million.

Who are the main players in the Monovalent Antivenom - Market report?

Ans: The main players in the Monovalent Antivenom - Market are CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Vins Bioproducts, Serum Biotech

What are the Application segmentation covered in the Monovalent Antivenom - Market report?

Ans: The Applications covered in the Monovalent Antivenom - Market report are Non-profit Institutions, Hospitals and Clinic

What are the Type segmentation covered in the Monovalent Antivenom - Market report?

Ans: The Types covered in the Monovalent Antivenom - Market report are Coral Snakes Antivenom, Sea Snakes Antivenom, Brown Snake Antivenom, Others

1 Market Overview
1.1 Monovalent Antivenom Product Introduction
1.2 Global Monovalent Antivenom Market Size Forecast
1.2.1 Global Monovalent Antivenom Sales Value (2019-2030)
1.2.2 Global Monovalent Antivenom Sales Volume (2019-2030)
1.2.3 Global Monovalent Antivenom Sales Price (2019-2030)
1.3 Monovalent Antivenom Market Trends & Drivers
1.3.1 Monovalent Antivenom Industry Trends
1.3.2 Monovalent Antivenom Market Drivers & Opportunity
1.3.3 Monovalent Antivenom Market Challenges
1.3.4 Monovalent Antivenom Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Monovalent Antivenom Players Revenue Ranking (2023)
2.2 Global Monovalent Antivenom Revenue by Company (2019-2024)
2.3 Global Monovalent Antivenom Players Sales Volume Ranking (2023)
2.4 Global Monovalent Antivenom Sales Volume by Company Players (2019-2024)
2.5 Global Monovalent Antivenom Average Price by Company (2019-2024)
2.6 Key Manufacturers Monovalent Antivenom Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Monovalent Antivenom Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Monovalent Antivenom
2.9 Monovalent Antivenom Market Competitive Analysis
2.9.1 Monovalent Antivenom Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Monovalent Antivenom Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monovalent Antivenom as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Coral Snakes Antivenom
3.1.2 Sea Snakes Antivenom
3.1.3 Brown Snake Antivenom
3.1.4 Others
3.2 Global Monovalent Antivenom Sales Value by Type
3.2.1 Global Monovalent Antivenom Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Monovalent Antivenom Sales Value, by Type (2019-2030)
3.2.3 Global Monovalent Antivenom Sales Value, by Type (%) (2019-2030)
3.3 Global Monovalent Antivenom Sales Volume by Type
3.3.1 Global Monovalent Antivenom Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Monovalent Antivenom Sales Volume, by Type (2019-2030)
3.3.3 Global Monovalent Antivenom Sales Volume, by Type (%) (2019-2030)
3.4 Global Monovalent Antivenom Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Non-profit Institutions
4.1.2 Hospitals and Clinic
4.2 Global Monovalent Antivenom Sales Value by Application
4.2.1 Global Monovalent Antivenom Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Monovalent Antivenom Sales Value, by Application (2019-2030)
4.2.3 Global Monovalent Antivenom Sales Value, by Application (%) (2019-2030)
4.3 Global Monovalent Antivenom Sales Volume by Application
4.3.1 Global Monovalent Antivenom Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Monovalent Antivenom Sales Volume, by Application (2019-2030)
4.3.3 Global Monovalent Antivenom Sales Volume, by Application (%) (2019-2030)
4.4 Global Monovalent Antivenom Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Monovalent Antivenom Sales Value by Region
5.1.1 Global Monovalent Antivenom Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Monovalent Antivenom Sales Value by Region (2019-2024)
5.1.3 Global Monovalent Antivenom Sales Value by Region (2025-2030)
5.1.4 Global Monovalent Antivenom Sales Value by Region (%), (2019-2030)
5.2 Global Monovalent Antivenom Sales Volume by Region
5.2.1 Global Monovalent Antivenom Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Monovalent Antivenom Sales Volume by Region (2019-2024)
5.2.3 Global Monovalent Antivenom Sales Volume by Region (2025-2030)
5.2.4 Global Monovalent Antivenom Sales Volume by Region (%), (2019-2030)
5.3 Global Monovalent Antivenom Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Monovalent Antivenom Sales Value, 2019-2030
5.4.2 North America Monovalent Antivenom Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Monovalent Antivenom Sales Value, 2019-2030
5.5.2 Europe Monovalent Antivenom Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Monovalent Antivenom Sales Value, 2019-2030
5.6.2 Asia Pacific Monovalent Antivenom Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Monovalent Antivenom Sales Value, 2019-2030
5.7.2 South America Monovalent Antivenom Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Monovalent Antivenom Sales Value, 2019-2030
5.8.2 Middle East & Africa Monovalent Antivenom Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Monovalent Antivenom Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Monovalent Antivenom Sales Value
6.2.1 Key Countries/Regions Monovalent Antivenom Sales Value, 2019-2030
6.2.2 Key Countries/Regions Monovalent Antivenom Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Monovalent Antivenom Sales Value, 2019-2030
6.3.2 United States Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Monovalent Antivenom Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Monovalent Antivenom Sales Value, 2019-2030
6.4.2 Europe Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Monovalent Antivenom Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Monovalent Antivenom Sales Value, 2019-2030
6.5.2 China Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
6.5.3 China Monovalent Antivenom Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Monovalent Antivenom Sales Value, 2019-2030
6.6.2 Japan Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Monovalent Antivenom Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Monovalent Antivenom Sales Value, 2019-2030
6.7.2 South Korea Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Monovalent Antivenom Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Monovalent Antivenom Sales Value, 2019-2030
6.8.2 Southeast Asia Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Monovalent Antivenom Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Monovalent Antivenom Sales Value, 2019-2030
6.9.2 India Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
6.9.3 India Monovalent Antivenom Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 CSL
7.1.1 CSL Company Information
7.1.2 CSL Introduction and Business Overview
7.1.3 CSL Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
7.1.4 CSL Monovalent Antivenom Product Offerings
7.1.5 CSL Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck Monovalent Antivenom Product Offerings
7.2.5 Merck Recent Development
7.3 BTG
7.3.1 BTG Company Information
7.3.2 BTG Introduction and Business Overview
7.3.3 BTG Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BTG Monovalent Antivenom Product Offerings
7.3.5 BTG Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Monovalent Antivenom Product Offerings
7.4.5 Pfizer Recent Development
7.5 Haffkine Bio-Pharmaceutical
7.5.1 Haffkine Bio-Pharmaceutical Company Information
7.5.2 Haffkine Bio-Pharmaceutical Introduction and Business Overview
7.5.3 Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Haffkine Bio-Pharmaceutical Monovalent Antivenom Product Offerings
7.5.5 Haffkine Bio-Pharmaceutical Recent Development
7.6 Vins Bioproducts
7.6.1 Vins Bioproducts Company Information
7.6.2 Vins Bioproducts Introduction and Business Overview
7.6.3 Vins Bioproducts Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Vins Bioproducts Monovalent Antivenom Product Offerings
7.6.5 Vins Bioproducts Recent Development
7.7 Serum Biotech
7.7.1 Serum Biotech Company Information
7.7.2 Serum Biotech Introduction and Business Overview
7.7.3 Serum Biotech Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Serum Biotech Monovalent Antivenom Product Offerings
7.7.5 Serum Biotech Recent Development
8 Industry Chain Analysis
8.1 Monovalent Antivenom Industrial Chain
8.2 Monovalent Antivenom Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Monovalent Antivenom Sales Model
8.5.2 Sales Channel
8.5.3 Monovalent Antivenom Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Monovalent Antivenom Market Trends
    Table 2. Monovalent Antivenom Market Drivers & Opportunity
    Table 3. Monovalent Antivenom Market Challenges
    Table 4. Monovalent Antivenom Market Restraints
    Table 5. Global Monovalent Antivenom Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Monovalent Antivenom Revenue Market Share by Company (2019-2024)
    Table 7. Global Monovalent Antivenom Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Monovalent Antivenom Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Monovalent Antivenom Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Monovalent Antivenom Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Monovalent Antivenom Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Monovalent Antivenom
    Table 13. Global Monovalent Antivenom Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monovalent Antivenom as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Monovalent Antivenom Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Monovalent Antivenom Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Monovalent Antivenom Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Monovalent Antivenom Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Monovalent Antivenom Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Monovalent Antivenom Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Monovalent Antivenom Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Monovalent Antivenom Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Monovalent Antivenom Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Monovalent Antivenom Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Monovalent Antivenom Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Monovalent Antivenom Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Monovalent Antivenom Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Monovalent Antivenom Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Monovalent Antivenom Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Monovalent Antivenom Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Monovalent Antivenom Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Monovalent Antivenom Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Monovalent Antivenom Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Monovalent Antivenom Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Monovalent Antivenom Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Monovalent Antivenom Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Monovalent Antivenom Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Monovalent Antivenom Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Monovalent Antivenom Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Monovalent Antivenom Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Monovalent Antivenom Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Monovalent Antivenom Sales Value by Region (2019-2024) & (%)
    Table 44. Global Monovalent Antivenom Sales Value by Region (2025-2030) & (%)
    Table 45. Global Monovalent Antivenom Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Monovalent Antivenom Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Monovalent Antivenom Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Monovalent Antivenom Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Monovalent Antivenom Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Monovalent Antivenom Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Monovalent Antivenom Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Monovalent Antivenom Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Monovalent Antivenom Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Monovalent Antivenom Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Monovalent Antivenom Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Monovalent Antivenom Sales Volume, (2025-2030) & (K Units)
    Table 57. CSL Company Information
    Table 58. CSL Introduction and Business Overview
    Table 59. CSL Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. CSL Monovalent Antivenom Product Offerings
    Table 61. CSL Recent Development
    Table 62. Merck Company Information
    Table 63. Merck Introduction and Business Overview
    Table 64. Merck Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Merck Monovalent Antivenom Product Offerings
    Table 66. Merck Recent Development
    Table 67. BTG Company Information
    Table 68. BTG Introduction and Business Overview
    Table 69. BTG Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. BTG Monovalent Antivenom Product Offerings
    Table 71. BTG Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Pfizer Monovalent Antivenom Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. Haffkine Bio-Pharmaceutical Company Information
    Table 78. Haffkine Bio-Pharmaceutical Introduction and Business Overview
    Table 79. Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Haffkine Bio-Pharmaceutical Monovalent Antivenom Product Offerings
    Table 81. Haffkine Bio-Pharmaceutical Recent Development
    Table 82. Vins Bioproducts Company Information
    Table 83. Vins Bioproducts Introduction and Business Overview
    Table 84. Vins Bioproducts Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Vins Bioproducts Monovalent Antivenom Product Offerings
    Table 86. Vins Bioproducts Recent Development
    Table 87. Serum Biotech Company Information
    Table 88. Serum Biotech Introduction and Business Overview
    Table 89. Serum Biotech Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Serum Biotech Monovalent Antivenom Product Offerings
    Table 91. Serum Biotech Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Monovalent Antivenom Downstream Customers
    Table 95. Monovalent Antivenom Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Monovalent Antivenom Product Picture
    Figure 2. Global Monovalent Antivenom Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Monovalent Antivenom Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Monovalent Antivenom Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Monovalent Antivenom Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Monovalent Antivenom Report Years Considered
    Figure 7. Global Monovalent Antivenom Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Monovalent Antivenom Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Monovalent Antivenom Revenue in 2023
    Figure 10. Monovalent Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Coral Snakes Antivenom Picture
    Figure 12. Sea Snakes Antivenom Picture
    Figure 13. Brown Snake Antivenom Picture
    Figure 14. Others Picture
    Figure 15. Global Monovalent Antivenom Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Monovalent Antivenom Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Monovalent Antivenom Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Monovalent Antivenom Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Monovalent Antivenom Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Non-profit Institutions
    Figure 21. Product Picture of Hospitals and Clinic
    Figure 22. Global Monovalent Antivenom Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Monovalent Antivenom Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Monovalent Antivenom Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Monovalent Antivenom Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Monovalent Antivenom Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Monovalent Antivenom Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Monovalent Antivenom Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Monovalent Antivenom Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Monovalent Antivenom Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Monovalent Antivenom Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Monovalent Antivenom Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Monovalent Antivenom Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Monovalent Antivenom Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Monovalent Antivenom Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Monovalent Antivenom Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Monovalent Antivenom Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Monovalent Antivenom Sales Volume (%), (2019-2030)
    Figure 39. United States Monovalent Antivenom Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Monovalent Antivenom Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Monovalent Antivenom Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Monovalent Antivenom Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Monovalent Antivenom Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Monovalent Antivenom Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Monovalent Antivenom Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Monovalent Antivenom Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Monovalent Antivenom Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Monovalent Antivenom Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Monovalent Antivenom Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Monovalent Antivenom Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Monovalent Antivenom Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Monovalent Antivenom Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Monovalent Antivenom Sales Value by Application (%), 2023 VS 2030
    Figure 60. Monovalent Antivenom Industrial Chain
    Figure 61. Monovalent Antivenom Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Barium Sulfate Suspension Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11W11297
Fri Feb 07 00:00:00 UTC 2025

Add to Cart

Global Radiation Relief Product Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5G11651
Fri Feb 07 00:00:00 UTC 2025

Add to Cart

Global Neomycin Sulphate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25E14350
Fri Feb 07 00:00:00 UTC 2025

Add to Cart

Global Pure NMN Powder Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32V14557
Fri Feb 07 00:00:00 UTC 2025

Add to Cart